Biomarin Pharmaceutical Inc
Change company Symbol lookup
Select an option...
BMRN Biomarin Pharmaceutical Inc
GEO Geo Group Inc
FMX Fomento Economico Mexicano SAB de CV
EPR EPR Properties
ILMN Illumina Inc
XFLT XAI Octagon Floating Rate & Alternative Income Term Trust
CZNC Citizens & Northern Corp
CYTK Cytokinetics Inc
CATM Cardtronics PLC
NREF Nexpoint Real Estate Finance Inc
Go

Health Care : Biotechnology | Mid Cap Blend
Company profile

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

Price
Delayed
$73.73
Day's Change
-0.695 (-0.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
74.27
Day's Low
72.52
Volume
(Below Average)

Today's volume of 466,988 shares is on pace to be lower than BMRN's 10-day average volume of 1,290,267 shares.

466,988
  • Prev Close
    74.42
  • Today's Open
    73.74
  • Day's Range
    72.52-74.27
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    11:57a ET 10/30/20
  • Last (size)
    100
  • 52-Wk Range
    68.25 - 131.95
    LowHigh
  • (03/23/20 - 07/21/20)
    8.02%
  • 61.0%
  • Market Cap
    13.3B
  • Shares Outstanding
    181.3M
  • 0.65
  • 113.96x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 99.02
  • (% of float 10/15/20)
    6.20

Latest News

October 29, 2020
1:37 pm ET
Accesswire
1:00 pm ET
Globe Newswire
12:35 pm ET
Zacks
6:08 am ET
Newsfile
October 28, 2020
10:50 pm ET
Globe Newswire
10:04 pm ET
Newsfile
5:49 pm ET
Accesswire
5:00 pm ET
Globe Newswire
4:31 pm ET
Newsfile
2:01 pm ET
Accesswire
11:46 am ET
Accesswire
8:00 am ET
Globe Newswire
6:20 am ET
Accesswire
October 27, 2020
10:50 pm ET
Globe Newswire
3:52 pm ET
Newsfile
1:31 pm ET
Newsfile
12:00 pm ET
Globe Newswire
11:41 am ET
Accesswire
11:00 am ET
Globe Newswire
6:20 am ET
Accesswire
October 26, 2020
10:50 pm ET
Globe Newswire
5:56 pm ET
Accesswire
5:26 pm ET
Globe Newswire
3:43 pm ET
Newsfile
2:27 pm ET
Accesswire
12:30 pm ET
Globe Newswire
6:20 am ET
Accesswire
October 25, 2020
12:42 pm ET
Globe Newswire
October 23, 2020
10:50 pm ET
Globe Newswire
4:55 pm ET
Accesswire
1:28 pm ET
Newsfile
12:00 pm ET
PR Newswire
6:20 am ET
Accesswire
October 22, 2020
10:51 pm ET
Newsfile
4:40 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.